Artificial intelligence (AI) and machine learning are becoming potent forces in surgical planning, intraoperative guidance, and postoperative monitoring for cataract procedures. As these technologies become more sophisticated, their influence over the US Cataract Surgery Device Market is growing. The MRFR data shows market size at USD 2.11 billion in 2023, with forecasts placing it at USD 4.5 billion by 2035, under a CAGR of roughly 5.489%.  By integrating AI into imaging, diagnostics, and laser control systems, device providers enable more accurate incision placement, better lens alignment, prediction of surgical complications, and personalized treatment plans. Data from large patient cohorts allows learning algorithms to refine preoperative assessments and improve intraoperative decision-making. Additionally, AI-assisted devices may help reduce surgical time and minimize human error. Regulatory and ethical considerations, including data privacy and validation of algorithmic accuracy, are becoming central to commercialization. The combination of hardware innovation (in IOLs, phacoemulsification, and OVDs) with intelligent software platforms may mark the next wave of competitive advantage.

AI holds promise for transforming surgical outcomes and reducing adverse events. But adoption will require robust data, transparent regulatory frameworks, and clinician confidence; success in these areas could accelerate growth beyond current projections.